Format

Send to

Choose Destination
Clin Infect Dis. 2011 Aug;53(4):363-8. doi: 10.1093/cid/cir410.

Coccidioidomycosis during pregnancy: a review and recommendations for management.

Author information

1
University of California, San Diego, California, USA.

Abstract

Pregnancy is an established risk factor for the development of severe and disseminated coccidioidomycosis, particularly when infection is acquired during the later stages of gestation. Although recent studies suggest that the incidence of symptomatic coccidioidomycosis during pregnancy is decreasing and that outcome has improved, management is complicated by the observations that azole antifungal agents can be teratogenic when given to some women, particularly at high doses, early in pregnancy. This article summarizes the data on these issues and offers guidance on the management of coccidioidomycosis during pregnancy.

PMID:
21810749
DOI:
10.1093/cid/cir410
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center